Delivery Order SPE2DB22D2206-SPE2DB24FGE48
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $2.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for Deferasirox 360 mg tablets in quantities of 30 tablets. This firm fixed price delivery order, valued at $9,492.73, was competitively awarded without a set-aside designation and carries an ultimate completion date of August 26, 2025. The award represents a child contract under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a completion date of February 1, 2024 and a potential value of $2,946.36. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract valued at $22,697.07, with an ultimate completion date of December 11, 2025. This non-set-aside delivery order represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting the agency's ongoing procurement of specialized pharmaceuticals to support military and federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, with a ceiling value of $34,899.12, is for the provision of Deferiprone 500 mg tablets to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of...
- The Defense Logistics Agency awarded a $49,888.19 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Deferasirox 360 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by December 10, 2025. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
- This is a firm fixed price delivery order for 360mg Deferasirox tablets awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $52,303.36 contract has a completion date of January 18, 2024 and was awarded on January 17, 2024. There was no set-aside designation used for this award. As a prime contractor, AmerisourceBergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, with a ceiling value of $41,885.03 for Deferasirox 500 mg tablets for suspension (30-count). The order is issued under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider. Place of performance is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...